Nosayaba Osazuwa-Peters1,2,3, Eric Adjei Boakye4, Betty Y Chen5, Betelihem B Tobo3, Mark A Varvares6. 1. Saint Louis University Cancer Center, St Louis, Missouri. 2. Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine, St Louis, Missouri. 3. Department of Epidemiology, Saint Louis University College of Public Health and Social Justice, St Louis, Missouri. 4. Saint Louis University Center for Outcomes Research, St Louis, Missouri. 5. Saint Louis University School of Medicine, St Louis, Missouri. 6. Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.
Abstract
IMPORTANCE: While the adverse association between smoking and head and neck squamous cell carcinoma (HNSCC) survival has been well described, there are also inconclusive studies and those that report no significant changes in HNSCC survival and overall mortality due to smoking. There is also a lack of studies investigating the association of marital status on smoking status at diagnosis for patients with HNSCC. OBJECTIVE: To examine the association between patient smoking status at HNSCC diagnosis and survival and the association between marital status and smoking in these patients. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted by querying the Saint Louis University Hospital Tumor Registry for adults with a diagnosis of HNSCC and treated at the university academic medical center between 1997 and 2012; 463 confirmed cases were analyzed. MAIN OUTCOMES AND MEASURES: Cox proportional hazards regression analysis was used to evaluate association of survival with smoking status at diagnosis and covariates. A multivariate logistic regression model was used to assess whether marital status was associated with smoking at diagnosis adjusting for covariates. RESULTS: Of the 463 total patients (338 men, 125 women), 92 (19.9%) were aged 18 to 49 years; 233 (50.3%) were aged 50 to 65 years; and 138 (29.8%) were older than 65 years. Overall, 56.2% of patients were smokers at diagnosis (n = 260); 49.6% were married (n = 228); and the mortality rate was 54.9% (254 died). A majority of patients were white (81.0%; n = 375). Smokers at diagnosis were more likely to be younger (ie, <65 years), unmarried, and to drink alcohol. We found a statistically significant difference in median survival time between smokers (89 months; 95% CI, 65-123 months) and nonsmokers at diagnosis (208 months; 95% CI, 129-235 months). In the adjusted Cox proportional hazards model, patients who were smokers at diagnosis were almost twice as likely to die during the study period as nonsmokers (hazard ratio, 1.98; 95% CI, 1.42-2.77). In the multivariate logistic regression analysis, unmarried patients were 76% more likely to use tobacco than married patients (adjusted odds ratio, 1.76; 95% CI, 1.08-2.84). CONCLUSIONS AND RELEVANCE: Smokers were almost twice as likely as nonsmokers to die during the study period. We also found that those who were married were less likely to be smokers at diagnosis. Our study suggests that individualized cancer care should incorporate social support and management of cancer risk behaviors.
IMPORTANCE: While the adverse association between smoking and head and neck squamous cell carcinoma (HNSCC) survival has been well described, there are also inconclusive studies and those that report no significant changes in HNSCC survival and overall mortality due to smoking. There is also a lack of studies investigating the association of marital status on smoking status at diagnosis for patients with HNSCC. OBJECTIVE: To examine the association between patient smoking status at HNSCC diagnosis and survival and the association between marital status and smoking in these patients. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted by querying the Saint Louis University Hospital Tumor Registry for adults with a diagnosis of HNSCC and treated at the university academic medical center between 1997 and 2012; 463 confirmed cases were analyzed. MAIN OUTCOMES AND MEASURES: Cox proportional hazards regression analysis was used to evaluate association of survival with smoking status at diagnosis and covariates. A multivariate logistic regression model was used to assess whether marital status was associated with smoking at diagnosis adjusting for covariates. RESULTS: Of the 463 total patients (338 men, 125 women), 92 (19.9%) were aged 18 to 49 years; 233 (50.3%) were aged 50 to 65 years; and 138 (29.8%) were older than 65 years. Overall, 56.2% of patients were smokers at diagnosis (n = 260); 49.6% were married (n = 228); and the mortality rate was 54.9% (254 died). A majority of patients were white (81.0%; n = 375). Smokers at diagnosis were more likely to be younger (ie, <65 years), unmarried, and to drink alcohol. We found a statistically significant difference in median survival time between smokers (89 months; 95% CI, 65-123 months) and nonsmokers at diagnosis (208 months; 95% CI, 129-235 months). In the adjusted Cox proportional hazards model, patients who were smokers at diagnosis were almost twice as likely to die during the study period as nonsmokers (hazard ratio, 1.98; 95% CI, 1.42-2.77). In the multivariate logistic regression analysis, unmarried patients were 76% more likely to use tobacco than married patients (adjusted odds ratio, 1.76; 95% CI, 1.08-2.84). CONCLUSIONS AND RELEVANCE: Smokers were almost twice as likely as nonsmokers to die during the study period. We also found that those who were married were less likely to be smokers at diagnosis. Our study suggests that individualized cancer care should incorporate social support and management of cancer risk behaviors.
Authors: Shrujal S Baxi; Laura C Pinheiro; Sujata M Patil; David G Pfister; Kevin C Oeffinger; Elena B Elkin Journal: Cancer Date: 2014-02-22 Impact factor: 6.860
Authors: R V M López; M A Zago; J Eluf-Neto; M P Curado; A W Daudt; W A da Silva-Junior; D L Zanette; J E Levi; M B de Carvalho; L P Kowalski; M Abrahão; J F de Góis-Filho; P Boffetta; V Wünsch-Filho Journal: Braz J Med Biol Res Date: 2011-08-12 Impact factor: 2.590
Authors: Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek Journal: Cancer Causes Control Date: 2010-04-17 Impact factor: 2.506
Authors: Sonia A Duffy; David L Ronis; Scott McLean; Karen E Fowler; Stephen B Gruber; Gregory T Wolf; Jeffrey E Terrell Journal: J Clin Oncol Date: 2009-03-16 Impact factor: 44.544
Authors: Dilyara G Yanbaeva; Mieke A Dentener; Eva C Creutzberg; Geertjan Wesseling; Emiel F M Wouters Journal: Chest Date: 2007-05 Impact factor: 9.410
Authors: Kristen McCarter; Úrsula Martínez; Ben Britton; Amanda Baker; Billie Bonevski; Gregory Carter; Alison Beck; Chris Wratten; Ashleigh Guillaumier; Sean A Halpin; Luke Wolfenden Journal: BMJ Open Date: 2016-09-20 Impact factor: 2.692
Authors: Eric Adjei Boakye; Paula Buchanan; Leslie Hinyard; Nosayaba Osazuwa-Peters; Mario Schootman; Jay F Piccirillo Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-08-01 Impact factor: 6.223
Authors: Anthony T Nguyen; Michael Luu; Jon Mallen-St Clair; Alain C Mita; Kevin S Scher; Diana J Lu; Stephen L Shiao; Allen S Ho; Zachary S Zumsteg Journal: JAMA Oncol Date: 2020-10-01 Impact factor: 31.777
Authors: Alexandra Iulia Irimie; Cornelia Braicu; Roxana Cojocneanu; Lorand Magdo; Anca Onaciu; Cristina Ciocan; Nikolay Mehterov; Diana Dudea; Smaranda Buduru; Ioana Berindan-Neagoe Journal: Int J Environ Res Public Health Date: 2018-07-23 Impact factor: 3.390